Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02659709 · ClinicalTrials.gov registry record

Interest in Electronic Applications for Patients With Glaucoma

A clinical trial, sponsored by Wills Eye.

Completed
Registry status
50
Enrollment target

NCT02659709: Completed study, sponsored by Wills Eye.

NCT02659709 is a clinical trial that has completed, run by Wills Eye. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02659709 has completed, sponsored by Wills Eye.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

Primary Outcome

Responses collected from participants about owning access to social media via smartphone or tablet technology obtained by completing a 20 item questionnaire.

Interventions

  • DEVICE Interest in medical education through social media

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2015-06
Est. Completion 2016-10
Wills Eye

59 total trials

What the finished NCT02659709 record still lists

NCT02659709 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Interest in medical education through social media is the first listed.

NCT02659709 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02659709 about?

NCT02659709 is a clinical study titled "Interest in Electronic Applications for Patients With Glaucoma". To evaluation interest in use of smartphone- and tablet-based application (app) for participants with glaucoma, ocular hypertension, those at risk and their caregivers.

What is the current status of trial NCT02659709?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2015-06. Estimated completion is 2016-10.

What interventions are being tested in trial NCT02659709?

The interventions under investigation include: Interest in medical education through social media (DEVICE).

Who is sponsoring clinical trial NCT02659709?

This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02659709, the US trial registry maintained by the National Library of Medicine. NCT02659709 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.